Thursday, November 5, 2026

AG Mortgage Investment Trust And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

AG Mortgage Investment Trust  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - AG Mortgage Investment Trust (MITT), Citizens Community Bancorp (CZWI), Pampa Energia S.A. Pampa Energia S.A. (PAM) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. AG Mortgage Investment Trust (MITT)

52.1% sales growth and 12.41% return on equity

AG Mortgage Investment Trust, Inc. operates as a residential mortgage real estate investment trust in the United States. Its investment portfolio comprises residential investments, including non-agency loans, agency-eligible loans, re-and non-performing loans, and non-agency residential mortgage-backed securities. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 2011 and is based in New York, New York.

Earnings Per Share

As for profitability, AG Mortgage Investment Trust has a trailing twelve months EPS of $1.85.

PE Ratio

AG Mortgage Investment Trust has a trailing twelve months price to earnings ratio of 3.72. Meaning, the purchaser of the share is investing $3.72 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.41%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 30.5%, now sitting on 70.19M for the twelve trailing months.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jun 28, 2024, the estimated forward annual dividend rate is 0.47 and the estimated forward annual dividend yield is 6.83%.

Yearly Top and Bottom Value

AG Mortgage Investment Trust's stock is valued at $6.88 at 01:22 EST, below its 52-week high of $6.99 and way above its 52-week low of $4.82.

2. Citizens Community Bancorp (CZWI)

17.2% sales growth and 7.99% return on equity

Citizens Community Bancorp, Inc. operates as a bank holding company for Citizens Community Federal N.A. that provides various traditional community banking services to businesses, agricultural operators, and consumers. The company accepts various deposit products, including demand deposits, savings and money market accounts, and certificates of deposit. It also offers various loan products comprising commercial real estate, commercial and industrial, agricultural real estate, agricultural operating, and consumer loans; and residential mortgages and home equity lines-of-credit. In addition, the company provides a portfolio of investments, such as mortgage-backed, corporate asset-backed, U.S. Government sponsored agency, corporate debt, and trust preferred securities. It operates through a network of 25 branch locations in Wisconsin and Minnesota. The company was founded in 1938 and is based in Eau Claire, Wisconsin.

Earnings Per Share

As for profitability, Citizens Community Bancorp has a trailing twelve months EPS of $1.29.

PE Ratio

Citizens Community Bancorp has a trailing twelve months price to earnings ratio of 8.81. Meaning, the purchaser of the share is investing $8.81 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.99%.

Sales Growth

Citizens Community Bancorp's sales growth is 17.2% for the ongoing quarter and 17.2% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 6.2%, now sitting on 60.01M for the twelve trailing months.

3. Pampa Energia S.A. Pampa Energia S.A. (PAM)

9.1% sales growth and 31% return on equity

Pampa Energía S.A. operates as an independent energy integrated company in Argentina. The company operates through Electricity Generation, Oil and Gas, Petrochemicals, and Holding and Other Business segments. It generates electricity through thermal generation plants, thermal gas-fired thermal generation plants, and hydroelectric power generation systems, as well as through a wind farm. The company also explores for and produces oil and gas; produces petrochemicals, such as styrene, styrene butadiene rubber, and polystyrene; and operates high voltage electricity transmission network. In addition, it engages in gas transportation and advisory services activities. The company was formerly known as Pampa Holding S.A. and changed its name to Pampa Energía S.A. in September 2008. Pampa Energía S.A. was incorporated in 1945 and is based in Buenos Aires, Argentina.

Earnings Per Share

As for profitability, Pampa Energia S.A. Pampa Energia S.A. has a trailing twelve months EPS of $8.95.

PE Ratio

Pampa Energia S.A. Pampa Energia S.A. has a trailing twelve months price to earnings ratio of 5.28. Meaning, the purchaser of the share is investing $5.28 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 302%, now sitting on 1.74T for the twelve trailing months.

4. Main Street Capital Corporation (MAIN)

7.4% sales growth and 19.45% return on equity

Main Street Capital Corporation is a principal investment firm that primarily provides equity capital to lower middle market companies and debt capital to middle market companies. Main Street's portfolio investments are typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. Main Street seeks to partner with entrepreneurs, business owners and management teams and generally provides "one stop" financing alternatives within its lower middle market portfolio. Main Street's lower middle market companies generally have annual revenues between $10 million and $150 million. Main Street's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies.

Earnings Per Share

As for profitability, Main Street Capital Corporation has a trailing twelve months EPS of $5.49.

PE Ratio

Main Street Capital Corporation has a trailing twelve months price to earnings ratio of 8.99. Meaning, the purchaser of the share is investing $8.99 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.45%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.4%, now sitting on 511.74M for the twelve trailing months.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter is a negative 3.8% and positive 2% for the next.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jun 21, 2024, the estimated forward annual dividend rate is 4.14 and the estimated forward annual dividend yield is 8.39%.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com